logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
L

Lung Cancer-Targets and Therapy

IF3.3
Papers76
Citations427
Journal Papers 76
Publication Date
delete
Response to Selpercatinib in a <em>CCDC6-RET</em> Lung Adenocarcinoma with an Acquired Novel <em>RET</em> p.L730_G731insL After Progression on Pralsetinib: A Case Report
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-05-20
delete0
deleteOAAI
deleteChunyu Tian; Yang Zou; Jinxin Liu; Jing Zhao; Simiao Tian; Ying Liu; Gang Wang
deleteShare
deleteSave
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
deleteLung Cancer-Targets and Therapy
IF3.3
delete2026-01-01
delete0
deleteOAAI
deleteLumjiaktase, Putthapoom; Kemawichanurat, Nanthisa; Santiwiwas, Kanthon; Kuttiyod, Thatchathum; Oranratnachai, Songporn; Trachu, Narumol; Monnamo, Nanamon; Khiewngam, Khantong; Simmalee, Kantapat; Reungwetwattana, Thanyanan
deleteShare
deleteSave
Alectinib Efficacy Post-Brigatinib Against Advanced <em>ALK</em>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
deletelung cancer targets and therapy
IF0
delete2025-08-12
delete0
deleteOAAI
deleteRenaud Descourt; Florian Guisier; Maurice Pérol; Jacques Cadranel; Helene Doubre; Michael Duruisseaux; Stéphane Culine; Bertrand Mennecier; Olivier Bylicki; Christos Chouaid; Laurent Greillier
deleteShare
deleteSave
Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review
deletelung cancer targets and therapy
IF0
delete2025-08-12
delete0
deleteOAAI
deleteShuangru Chen; Liting Zhang; Jun Wang; Jiayao Lu; Ye Chen; Mingzhu Ling
deleteShare
deleteSave
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
deletelung cancer targets and therapy
IF0
delete2025-06-28
delete0
deleteOAAI
deleteMatteo Canale; Alessandra Virga; Davide Angeli; Eugenio Fonzi; Letizia Gnetti; Alessandra Dubini; Gianluca Tedaldi; Milena Urbini; Giovanni Bocchialini; Elisabetta Petracci; Alberto Verlicchi; Paola Cravero; Fabrizio Citarella; Chiara Bennati; Kalliopi Andrikou; Angelo Delmonte; Lucio Crinò; Paolo Carbognani; Paola Ulivi; Luca Ampollini
deleteShare
deleteSave
Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma
deletelung cancer targets and therapy
IF0
delete2025-06-09
delete0
deleteOAAI
deleteHe Du, Xinyu Song, Fengying Wu
deleteShare
deleteSave
Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
deletelung cancer targets and therapy
IF0
delete2025-05-27
delete0
deleteOAAI
deleteEmma Polonio-Alcalá; Sira Ausellé-Bosch; Gerard Riesco-Llach; Pablo Novales; Lidia Feliu; Marta Planas; Joaquim Ciurana; Teresa Puig
deleteShare
deleteSave
LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of <em>EGFR</em>+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III <em>EGFR</em>-Mutated NSCLC Compared to Placebo (LAURA; NCT03521154)
deletelung cancer targets and therapy
IF0
delete2025-04-25
delete0
deleteOAAI
deleteFaustine X Luo; Zhaohui Arter; Sai-Hong Ignatius Ou; Misako Nagasaka
deleteShare
deleteSave
Prevalence of <em>EGFR</em> Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study
deletelung cancer targets and therapy
IF0
delete2025-04-21
delete0
deleteOAAI
deleteTu Van Dao; Van Luong Dinh; Thanh Vinh Doan; Tri Le Phuong
deleteShare
deleteSave
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer
deletelung cancer targets and therapy
IF0
delete2025-04-12
delete0
deleteOAAI
deleteChing-Yi Chen; How-Wen Ko; Po-Wei Hu; Cheng-Yu Chang; Chung-Yu Chen; Shih-Chieh Chang; Yu-Chi Chiu; Yu-Feng Wei
deleteShare
deleteSave
Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I; II; III) of <em>BRAF</em> Mutated (<em>BRAF+</em>) NSCLC
deletelung cancer targets and therapy
IF0
delete2025-02-19
delete0
deleteOAAI
deleteZhaohui Liao Arter; Kevin Shieh; Misako Nagasaka; Sai-Hong Ignatius Ou
deleteShare
deleteSave
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2025-02-01
delete0
deleteOAAI
deleteCanale, Matteo; Urbini, Milena; Petracci, Elisabetta; Angeli, Davide; Tedaldi, Gianluca; Priano, Ilaria; Cravero, Paola; Flospergher, Michele; Andrikou, Kalliopi; Bennati, Chiara; Tassinari, Davide; Dubini, Alessandra; Rossi, Giulio; Panzacchi, Riccardo; Valli, Mirca; Bronte, Giuseppe; Crino, Lucio; Delmonte, Angelo; Ulivi, Paola
deleteShare
deleteSave
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-12-01
delete0
deleteOAAI
deleteLee, Alexandria T. M.; Nagasaka, Misako
deleteShare
deleteSave
Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-10-01
delete0
deleteOAAI
deleteLuo, Faustine X.; Arter, Zhaohui Liao
deleteShare
deleteSave
NRG1 Fusions in NSCLC: Being eNRGy Conscious
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-10-01
delete1
deleteOAAI
deleteGupta, Brinda; Barrett, Laura Gosa; Liu, Stephen, V
deleteShare
deleteSave
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-10-01
delete0
deleteOAAI
deleteShim, Joo Sung; Kim, Youhyun; Yuh, Taeho; Lee, Jii Bum; Kim, Hye Ryun; Hong, Min Hee; Cho, Byoung Chul; Lim, Sun Min
deleteShare
deleteSave
Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-08-01
delete0
deleteOAAI
deleteArter, Zhaohui Liao; Nagasaka, Misako
deleteShare
deleteSave
Pulmonary Spindle Cell Carcinoma Mimicking Granulomatous Inflammation: A Rare Case Report and Brief Review of the Literature
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-08-01
delete0
deleteOAAI
deleteLiu, Qian; Zhang, Jun; Wei, Mingqin; Zhou, Xue; Sun, Hao; Dong, Youhong; Zhang, Dongdong
deleteShare
deleteSave
Mutation of MET D1228N as an Acquired Potential Mechanism of Crizotinib Resistance in NSCLC with MET Y1003H Mutation
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-08-01
delete0
deleteOAAI
deleteZhu, Jinlian; Chen, Jie; Liu, Wei; Zhang, Junling; Gu, Yulan
deleteShare
deleteSave
Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?
deleteLUNG CANCER-TARGETS AND THERAPY
IF3.3
delete2024-07-01
delete2
deleteOAAI
deleteArter, Zhaohui Liao; Nagasaka, Misako
deleteShare
deleteSave